DHA Oral Supplementation Modulates Serum Epoxydocosapentaenoic Acid (EDP) Levels in Breast Cancer Patients

Table 2

Participants’ characteristics.

All participants	S group	F group	M group	C group
Age, years
Body weight, kg
BMI, weight (kg)/height^2 (m)
Cholesterol, mg/dL
Glycemia, mg/dL
Comorbidities^# (y/no)	3/7	3/9	2/9	1/9
Ln EDPs (ng/mL) at T0
Ln EDPs (ng/mL) at T1

Data are shown as . values are not significant for the patients’ characteristics shown between groups. Abbreviations include: S: sporadic group; F: familiar group; M: mutated group; C: control group; BMI: body mass index; EDPs: epoxydocosapentaenoic acids. ^#Dyslipidemia and type 2 diabetes.